ω-3 fatty acids attenuate mucosal inflammation in premature rat pups

J Pediatr Surg. 2011 Mar;46(3):489-95. doi: 10.1016/j.jpedsurg.2010.07.032.

Abstract

Background: Necrotizing enterocolitis (NEC) is a devastating intestinal disease of premature infants. Although ω-3 fatty acids are known to have antiinflammatory effects, their effect against NEC remains unclear.

Methods: Mother rats fed a soybean-based, docosahexaenoic acid (DHA)- or eicosapentaenoic acid (EPA)-enriched diet from days 7 to 20 of gestation were examined. On day 20, the rat pups were delivered by abdominal incision, their intestines were removed, and messenger RNA was extracted. A rat NEC model was used to confirm the effects of ω-3 fatty acids on the inflamed intestine (n = 20-28). The expression of inflammatory molecules was analyzed by real-time polymerase chain reaction (n = 11-14).

Results: The concentrations of DHA and EPA in the intestine were significantly increased in the DHA and EPA groups (P < .01). The expression of the antiinflammatory prostaglandin E2 receptor EP3 was increased in the DHA (P < .05) and EPA groups (P < .01). In the NEC model, the reduced incidence of colitis was confirmed in the DHA and EPA groups. The expression of peroxisome proliferator-activated receptor γ was increased (P < .05), and the inhibitor of nuclear factor-κB α/β decreased in both the DHA (P < .01) and EPA groups (P < .05).

Conclusion: Our findings indicate that ω-3 fatty acids are beneficial for protecting the premature intestine from inflammation by regulating eicosanoid- and nuclear factor-κB-related metabolite expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Dietary Fats, Unsaturated / administration & dosage
  • Dietary Fats, Unsaturated / therapeutic use*
  • Disease Models, Animal
  • Docosahexaenoic Acids / administration & dosage
  • Docosahexaenoic Acids / pharmacology
  • Docosahexaenoic Acids / therapeutic use*
  • Drug Evaluation, Preclinical
  • Eicosapentaenoic Acid / administration & dosage
  • Eicosapentaenoic Acid / pharmacology
  • Eicosapentaenoic Acid / therapeutic use*
  • Enterocolitis, Necrotizing / chemically induced
  • Enterocolitis, Necrotizing / prevention & control*
  • Fatty Acids / analysis
  • Female
  • Gene Expression Regulation / drug effects
  • Ileum / chemistry
  • Ileum / drug effects
  • Ileum / embryology
  • Infant Food / toxicity
  • Intestinal Mucosa / drug effects
  • Maternal-Fetal Exchange
  • Models, Animal
  • NF-kappa B / drug effects
  • PPAR gamma / biosynthesis
  • PPAR gamma / genetics
  • Pregnancy
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Prostaglandin E, EP3 Subtype / biosynthesis
  • Receptors, Prostaglandin E, EP3 Subtype / genetics
  • Soybean Oil
  • Specific Pathogen-Free Organisms

Substances

  • Anti-Inflammatory Agents
  • Dietary Fats, Unsaturated
  • Fatty Acids
  • NF-kappa B
  • PPAR gamma
  • Receptors, Prostaglandin E, EP3 Subtype
  • Docosahexaenoic Acids
  • Soybean Oil
  • Eicosapentaenoic Acid